Blue Horseshoe Stocks: GSK Recap & More

GlaxoSmithKline plc GSK – Update

We attempted to keep our excellent 2019 options performance intact yesterday, and we did see some chances for intraday gains in the fresh idea for GSK we included in our premarket report.

The stock didn’t skyrocket by any means, rising by less than a dollar, but the activity was sufficient to produce the following moves in our designated contracts.

$39.50 Calls – Range: .65-1.24 – Max Gain: 91%
$40 Calls – Range: .15-.75 – Max Gain: 400%
$40.50 Calls – Range: .10-.40 – Max Gain: 300%

Fresh Idea:
GRUB Weekly $86-87.50 Calls

Calix, Inc. CALX &
Vanda Pharmaceuticals, Inc. VNDA

We want to group these two stocks together this morning and tag them as bottom-watch plays. We’ll observe for the establishment of higher lows after their recent selloffs.

Both are now in the position of being extremely oversold, and exhibiting many of the conditions we routinely look for in potential recovery plays. We’ll observe their activity as we head into the end of the week.

Extended Watchlist:

Blue Horseshoe Stocks: VNDA, NQ & More

NQ Mobile, Inc. NQ

Yesterday, we pointed out all the reasons why we felt that NQ was in a good position to make a run, and we certainly hope folks took it to heart, because the stock followed it up with an solid session.

We first observed a morning low of 9.40, and NQ subsequently made a healthy move to a high of 10.85 on the afternoon, which was good for an intraday gain of 15%

On the options side of things, the $10 Calls dipped as low as .35, and went on to trade as high as a 1.00. This provides a good example of why we’ve gotten more and more into trading options on big board plays. Even just a modest move on the chart can translate into huge gains on the right contracts.

NQ is gapping up to the tune of another 5% this morning, so we’ll continue to keep an eye on things as we head into week’s end.

So far, from the low we observed following our tag of NQ toward the end of last month (6.25) we’ve seen gains on the order of 77%

Vanda Pharmaceuticals, Inc. VNDA

VNDA was another NASDAQ-listed stock that appeared in yesterday’s report on the Extended Watchlist. It would trade in a range from 11.00-12.99, an 18% increase. Another modest move compared to what we’re accustomed to with the pennies, but coming from a big board play, 18% in a single afternoon is very impressive.

Like NQ, VNDA was trading near a relative bottom when we passed it along to readers, and with this new-found momentum, it will be interesting to see what happens next.

Whether or not VNDA can crack through its 50DMA (13.04) is going to be the deciding factor as to whether there’s more upside here. Yesterday’s high came in just shy of that mark, so we’ve got some resistance to contend with, but we’ll certainly be monitoring very closely for a break of that level on the chart.

Shamika 2 Gold, Inc. SHMX

SHMX is a sub-penny breakout play that we want to add to our radar this morning. Yesterday the stock traded 9x its 3-month average volume, and traded in a range from .0003-.0006. It always a good idea to be cautious when dealing with these triple-zero stocks, but as most of you know, when the potential risk is high, the potential rewards can be even higher.

We’re going to monitor this play for further activity, more specifically, a potential dip-and-rip. Should SHMX taper off and pull back, that’s where we’ll be waiting to strike. Correctly timing the bottom on one of these super–subpenny stocks can treat traders to a heck of a bounceplay as we’ve seen so many times in the past.

Side Note: AAPL Options

AAPL continued to break out yesterday past last week’s swing high of 644.17. Remember, on Monday we reminded everyone that the AAPL options chain was a good candidate to provide us with opportunities over the course of the week, and that has certainly been true thus far.  The $640 Calls were as cheap as 1.35 on that day, and by yesterday, they were going for as much as 9.50.

Huge moves like that have almost become commonplace, as we’ve tracked AAPL through a more-than 100-dollar increase in just the past couple of months.

Extended Watchlist:

Blue Horseshoe Stocks: PBR, NQ & Extended Watchlist

Petroleo Brasiliero (Petrobras) PBR

PBR, which did so well for us earlier this year, is a point of focus for us once again. Since the huge gains the stock afforded us from March-May, it has consolidated a bit, and bounced off the 200DMA (Currently 13.69). We are turning our attention to PBR once again, because we want to be ready when the next upswing comes into effect.

We’d like to see support hold off of the 200DMA, and for the stock to make higher highs and higher lows to confirm the trend. When that occurs, we’ll be turning to the options chain as we did this spring,  and presently, we have our eyes on the 07/19 $15 Calls, which as of yesterday were trading in the .30-.38 range.

In the event that the stock tests its recent swing high of 15.85 by the expiration date, it could spell a double or triple for those contracts, so we’ll really want to keep a close watch. 

NQ Mobile, Inc. NQ

We’ve been tracking NQ this week; including the play in Monday’s Extended Watchlist, and this morning, we are seeing some serious pre-market activity on the stock. It is coming off of a recent bottom, and has already begun to fill one of the gaps on the chart this morning (Up to a high 10.45).

This morning’s announcement  is regarding the independent findings of the investigative committee assigned to look into fraud allegations levied against the company in the fall. NQ looks as if it will be cleared of any wrongdoing, and that appears to be contributing to this morning’s spike.

We could be looking into this one at just the right time; in addition to this morning’s good news, the company is also due to release its annual financials, and some positive figures could add even more fuel to the fire. Conditions appear to be reaching an ideal level for us to potentially register some sizable gains with this play.

Extended Watchlist:

PLUG, YRCW, VNDA, PCGX, FNMA, FMCC & Extended Watchlist

Plug Power, Inc. PLUG
PLUG continues to be a winner for us, seemingly, every time we mention it in one of our reports. Yesterday, we were anticipating a potentially profitable session based on observed indicators on the chart, and once again our timing proved to be extremely accurate.After touching a low of .58 early in the day, PLUG would climb for the rest of the session, closing at its high-of-day, .67. That represents a solid 16% increase on slightly less than twice the 3mo. average volume. With a head of steam like that building, we’ll be sure to continue monitoring PLUG today.

YRC Worldwide, Inc. YRCW

On Wednesday, YRCW appeared in our extended watchlist as a play that was gapping down, noting that we were on the lookout for a reversal. That’s just what happened, as we observed a 13% intraday move from the stock on that day. We continued to monitor YRCW yesterday and were once again met with positive results.

Trading in a daily range from a low of 7.51, YRCW was up as high as 8.699, marking a 16% intraday gain.

Vanda Pharmaceuticals, Inc. VNDA

After an appearance in Tuesday’s extended watchlist, and a feature in Wednesday’s report, wherein we were expecting FDA-related news from VNDA regarding a New Drug Application. The result was so highly-anticipated that it warranted NASDAQ to halt the stock on Thursday.

The FDA committee indeed met and are recommending approval of the company’s drug “tasimelteon, proposed tradename HETLIOZ(TM), for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind.” Non-24 is

As expected, the stock has resumed trading today and is gapping up this morning, with trades going off in the 14.60-16.50 range. This is already a substantial increase from our initial alert price at 11.07, and with positively-charged FDA news hot off the presses, profit margins could very well expand even further.

Virtual Sourcing, Inc. PGCX

Our timing was just a little bit early in our October 24th mention of PGCX. We were looking out for a bottom that would take until early last week to occur. However, when it did, it bounced off of support at .08, and subsequently made a 100% rip to .16.

The stock caught our eye yesterday, as it appeared to be searching out support once again, and found it at .09. We are curious to see how high the resulting bounce here could be in comparison to the one we observed previously.

Fannie Mae FNMA
& Freddie Mac FMCC

We follow this mortgage lending pair fairly regularly, and began re-introducing them onto our main watchlist on October 24th. At the time FNMA was trading as low as 1.86, and FMCC at 1.69.  Each has been on a steady increase since that time, with Fannie hitting a high of 3.08, and Freddie, 2.90. Both show no signs of relenting today, and are gapping up in premarket trading. (FNMA last traded at 3.42, FMCC at 3.30)

Some of you might remember the gains amounting to 350% we saw from these play earlier this year, so if past results are any indication of what we can expect from these two moving forward, we could be in for yet another wild ride at their expense.

Extended Watchlist:

CETV, VNDA, PHOT & Extended Watchlist

Central European Media Enterprises, Inc. CETV

We first caught CETV off of one of our From-4 scans back on May 10th. Time Warner had just purchased a block of shares worth close to $75M, and it caused us to take notice of the stock. At the time, we observed trades as low as 2.67.

As you can see on the chart below, CETV was on a fairly steady incline after that, recently (10/25) hitting a high of 6.60, a 147% move off of our observed bottom.

Shortly thereafter the stock would be subject to a big gap-down, and would continue to pull back to its current price in the low 2.00-range. The chart indicates that CETV is extremely oversold, and it has made higher lows over the past few sessions as it attempts to reverse its course. We want to keep our eyes peeled to this one, because conditions seem to be ripening for what could be a heck of a rebound.

Vanda Pharmaceuticals, Inc. VNDA

VNDA was a momentum play that we caught and included in yesterday’s extended watchlist. The company currently has a NDA (new drug application) filed with the FDA that treats chronic circadian arrhythmia.

After touching a low of 11.07 we saw a subsequent high of 13.49, a 22% intraday gain.

Growlife, Inc. PHOT

PHOT continues to be among our favorite medical/legal marijuana stocks, a play that we’ve followed for well over a year. Beginning at the end of August, trading at .0318, we realerted PHOT and began talking about it more and more.  We posted another reminder on the 16th of September, and once again on October 22nd, when we mentioned that a golden cross on the chart was imminent.

During yesterday’s session PHOT hit .1029, which marks a 224% increase off of the bottom we observed in late August. Even those who missed that report, could have caught the stock as low as .042 following the 09/16 reminder, for up to a 125% gain at yesterday’s high. From the third report we mentioned (10/22), significant gains to the tune of 43% from .0719-.1029 could have been achieved.

Extended Watchlist:
VDSC,  NURO, MSTX, FU, SUTR, YRCW(Huge gap down looking for reversal)
PBPB(Gapping up on positive earnings looking for continuation)